Somewhat Positive Media Coverage Somewhat Unlikely to Affect DENTSPLY SIRONA (XRAY) Share Price

News coverage about DENTSPLY SIRONA (NASDAQ:XRAY) has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. DENTSPLY SIRONA earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave news articles about the medical instruments supplier an impact score of 46.8737731074659 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

DENTSPLY SIRONA (NASDAQ:XRAY) traded up $0.19 on Wednesday, reaching $57.18. 1,836,871 shares of the company’s stock were exchanged, compared to its average volume of 2,517,827. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21. The stock has a market cap of $13,090.00, a P/E ratio of -16.43, a price-to-earnings-growth ratio of 2.12 and a beta of 1.17. DENTSPLY SIRONA has a 1 year low of $52.53 and a 1 year high of $68.98.

The business also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -10.06%.

Several analysts recently issued reports on XRAY shares. Stifel Nicolaus reissued a “buy” rating on shares of DENTSPLY SIRONA in a research report on Thursday, October 19th. Robert W. Baird set a $63.00 price objective on shares of DENTSPLY SIRONA and gave the stock a “buy” rating in a report on Thursday, October 19th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price objective on the stock in a report on Monday, November 6th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $68.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, November 6th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $69.15.

In related news, Director Eric Brandt sold 6,409 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the transaction, the director now directly owns 12,073 shares of the company’s stock, valued at approximately $821,446.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.99% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at


DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Insider Buying and Selling by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply